CAMBRIDGE, Mass.--(BUSINESS WIRE)--Ironwood Pharmaceuticals, Inc. announced today the launch of an updated direct-to-consumer (DTC) awareness campaign for LINZESS® (linaclotide). Please see full Prescribing Information including Boxed Warning at http://www.frx.com/pi/linzess_pi.pdf. The company has made the television advertisement available on Business Wire's website and YouTube channel. More information about LINZESS is available at www.linzess.com.
LINZESS® is a trademark owned by Ironwood Pharmaceuticals, Inc. Any other trademarks referred to in this alert are the property of their respective owners. All rights reserved.
